Elaia

Elaia is a Paris-based venture capital firm established in 2002, managing over €700m. It specializes in early-stage investments, focusing on disruptive startups in the digital economy, deep tech, and software technology sectors across Europe and Israel. With a team boasting over 75 years of combined experience in venture capital and digital industries, Elaia provides close, proactive support to its entrepreneurs, aiming to help them grow into global leaders.

Anne-Sophie Carrese

Partner

Sofia Dahoune

Investor

Florian Denis

Investment Director

Clément Vanden Driessche

Investment Director

Clement Vanden Driessche

Investment Director

Gabriel Franz

Investment Manager

Alexis Frentz

Investment Director

Benoit Georis

Investment Director

Philippe Gire

Partner

Amélie Juge

Associate

Samantha Jerusalmy

Partner

Xavier Lazarus

Partner

Franck Lescure

Partner

Maxime Lhoustau

Associate

Sacha Loiseau

Venture Partner

Gabriel Levy

Associate

Julien Macquet

Associate

Alexandre Ouimet-Storrs

Venture Partner

Céline Passedouet

Investment Director

Emmanuel Perez-Duarte

CFO

Daniel Pilaud

Venture Partner

Christophe Primault

Venture Partner

Marc Rougier

Partner

Manon Sorroche

Associate

David Sourdive

Venture Partner

Armelle de Tinguy

Investment Manager

202 past transactions

Hema.to

Seed Round in 2025
Hema.to is a developer of clinical support software that specializes in automated, AI-powered detection suggestions for blood cancer, utilizing flow cytometry data. The company's platform offers comprehensive decision support, taking users from raw flow files to complete diagnostic reports. By focusing on the needs of hematology laboratories, Hema.to aims to enhance operational efficiency while ensuring high-quality results. Its tools are specifically designed to meet the unique requirements of clinical flow, empowering labs to provide better patient care through advanced technology.

Zymvol Biomodeling

Seed Round in 2025
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.

GetVocal AI

Seed Round in 2025
GetVocal AI is help companies automate customer service processes with the most advanced Conversational AI phone agent.

Alice & Bob

Series B in 2025
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company's innovative technology features self-correcting superconducting quantum bits, which allow for fault-tolerant quantum computing. This capability enables the execution of any quantum algorithm, thereby assisting industries and researchers in addressing complex challenges across various fields. By focusing on developing advanced quantum computing solutions, Alice & Bob aims to facilitate breakthroughs in solving significant problems in quantum research and industry applications.

AQEMIA

Series A in 2024
AQEMIA is a pharmatech company focused on drug discovery, utilizing a platform that integrates machine learning with quantum-inspired physics. This innovative approach allows for the efficient identification of new drug candidates aimed at specific therapeutic targets. By employing advanced algorithms, AQEMIA's platform is capable of predicting the interactions and affinities between potential drug molecules and their targets. This methodology not only accelerates the drug discovery process but also contributes to a growing pipeline of viable drug candidates for various medical applications.

Dunia Innovations

Venture Round in 2024
Dunia Innovation is developing the world's first self-driving laboratory aimed at advancing electrocatalytic carbon dioxide utilization. This innovative facility is designed to significantly accelerate catalyst research, addressing the challenges associated with scalable carbon utilization. By focusing on creating a circular carbon economy, Dunia Innovation seeks to transform carbon dioxide into valuable chemicals and fuels. This approach not only helps businesses understand their carbon footprints but also supports the broader goal of achieving net-zero emissions by reducing overall emissions.

Qantev

Series B in 2024
Qantev operates an AI-driven health claims platform designed for health and life insurance companies. The platform utilizes a proprietary algorithm to enhance the configuration of provider networks and identify optimal participants, thereby assisting insurers in minimizing claims leakage. By leveraging historical claims data, Qantev's technology empowers health insurance teams to gain valuable insights, facilitating data-driven decision-making and the development of effective business strategies. This innovative approach aims to improve efficiency and accuracy in claims operations across the global insurance market.

SurgAR

Venture Round in 2024
SurgAR specializes in augmented reality software tailored for computer-aided laparoscopic surgery. Its innovative solution offers a plug-and-play system that enhances minimally invasive surgical procedures. The software is designed to automatically detect tumors that require resection and highlights critical anatomical structures, thereby assisting surgeons in navigating complex surgical environments more effectively. By streamlining the surgical process, SurgAR aims to improve surgical outcomes and enhance the overall efficiency of laparoscopic procedures.

Doccla

Series B in 2024
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.

Continuity

Series A in 2024
Continuity offers a software-as-a-service (SaaS) platform that utilizes artificial intelligence and open data to identify outdated or invalid insurance contracts. The platform operates across four key product lines: Professional Indemnity, Commercial Property, Construction Workers Insurance, and Directors & Officers Liability. By analyzing data consistently and at scale, Continuity provides insurers with a comprehensive view of small and medium-sized enterprises (SMEs), ensuring that each business is adequately covered throughout its lifecycle. This innovative approach helps to enhance the accuracy and reliability of insurance coverage for SMEs.

Mitiga Solutions

Series A in 2024
Mitiga Solutions, S.L. is a Barcelona-based company that specializes in data science solutions focused on evaluating and managing volcanic hazards, alongside other natural risks such as sandstorms and wildfires. Incorporated in 2018, the company utilizes a computational platform, TAULA, which employs advanced predictive analytics, an early warning system, and weather and catastrophe risk modeling to enhance risk management for clients in aviation, insurance, humanitarian, and other sectors. Mitiga Solutions combines scientific knowledge with artificial intelligence and high-performance computing to provide climate risk intelligence, enabling organizations to analyze and respond to their exposure to climate-related threats. Its solutions facilitate real-time monitoring of natural hazards and assess their impacts, thereby aiding clients in making informed and timely decisions to bolster resilience against these risks.

NcodiN

Seed Round in 2024
NcodiN develops nanophotonic chips for data transport for processors that improves speed, energy efficiency and heating of the circuit

inHEART

Series A in 2024
inHEART specializes in advanced precision medicine for cardiology, utilizing artificial intelligence to enhance the care of patients with cardiac diseases. The company develops innovative software solutions that create a digital twin of the heart, transforming preoperative medical images into a detailed model. This technology aids cardiologists in diagnosing, planning, and navigating procedures related to heart rhythm disorders, such as arrhythmias and heart failure. By bridging the gap between radiology and cardiology, inHEART aims to improve treatment personalization and reduce procedure durations and failure rates, ultimately advancing patient care in the field of cardiovascular medicine.

Pixacare

Venture Round in 2024
Pixacare is a company that develops a medical imaging application aimed at enhancing wound care management for healthcare professionals. This secure and collaborative platform automates medical photo management and centralizes essential data for monitoring wounds, making it user-friendly on both mobile and desktop devices. The application is a Class I CE-marked digital medical device that integrates seamlessly with existing healthcare infrastructures, including Patient Administration Systems and Electronic Health Records, ensuring interoperability. By transforming any smartphone camera into a secure documentation tool, Pixacare enables home-care staff, surgeons, and dermatologists to monitor and anticipate complications in chronic and post-surgery wounds. This innovation allows healthcare professionals to optimize their activities and save time in visual specialties while ensuring data security through hosting on certified Health Data Hosting servers.

FlexAI

Seed Round in 2024
Unlocking the future of Machine Intelligence by rearchitecting the compute infrastructure

Nijta

Pre Seed Round in 2024
Nijta provides a robust and secure speech anonymization solution to contact centers to access high-quality data for voice analytics.

Vibe

Series A in 2024
Vibe is a developer of a programmatic advertising platform that specializes in detecting and targeting audiences through keyword identification. The platform enhances customer engagement by pinpointing specific sections that can improve attention and interaction. By creating targeted strategies and campaigns based on keyword searches, Vibe enables web agencies and advertisers to effectively retarget users and capture their intent. This capability ultimately aims to boost sales and improve the overall effectiveness of advertising efforts in the digital landscape.

Composable Prompts

Seed Round in 2024
We aim to revolutionize the way applications interact with content. While Large Language Models (LLMs) like GPT have fundamentally changed our interaction with textual data, we believe in taking a step further. Composable Prompts ensures that every business, regardless of its scale or domain, can leverage the native data processing capabilities of LLMs in the most efficient way possible. We've built the API Studio for LLMs, a comprehensive toolkit for designing, deploying, and operating business-specific APIs. Our suite offers a structured, domain-specific approach, shifting from rudimentary, text-based interactions to a world of structured, efficient, and integrated content processing. Our Core Offerings: Interaction Designer: Crafting intuitive prompt templates and robust data schemas. Prompt Assistance: Using LLMs to enhance prompt design and offer improvement suggestions. API Service: Seamlessly integrating LLMs into your applications and business processes. Cache Service: Ensuring optimal performance by intelligently storing and reusing Interaction Results. Collaboration & Optimization Tools: From sharing prompt segments to monitoring performance, we have developers covered.

AQEMIA

Series A in 2024
AQEMIA is a pharmatech company focused on drug discovery, utilizing a platform that integrates machine learning with quantum-inspired physics. This innovative approach allows for the efficient identification of new drug candidates aimed at specific therapeutic targets. By employing advanced algorithms, AQEMIA's platform is capable of predicting the interactions and affinities between potential drug molecules and their targets. This methodology not only accelerates the drug discovery process but also contributes to a growing pipeline of viable drug candidates for various medical applications.

HEPHAISTOS-Pharma

Seed Round in 2024
Hephaistos Pharma is a biotechnology company focused on advancing oncology treatments through innovative immunotherapy solutions. The firm develops a platform that utilizes active and non-specific immuno-stimulants to enhance the effectiveness of existing antibodies by transforming cold tumors into hot targets, which can significantly improve patient outcomes. This approach aims to address unmet medical needs in cancer treatment, enabling patients to tackle previously incurable cancers. Hephaistos Pharma is dedicated to elevating immunotherapy efficiency by stimulating immune responses, thereby offering new hope in the fight against cancer. Interested parties can access more information through an online inquiry form available on the company's website.

Phospho

Pre Seed Round in 2024
Phospho is Amplitude for LLM applications. Allowing Product Managers to quantify usage, quality, user engagement of LLM apps.

SUN ZU Lab

Seed Round in 2024
SUN ZU Lab is an independent provider of liquidity analytics for crypto professionals. Clients can use SUN ZU Lab's liquidity analytics to determine whether their order book is strong on its own and in comparison to key competitors. With a clear and demonstrable value proposition, clients are better equipped to serve existing investors and attract new ones. SUN ZU Lab's mission is to increase transparency in the thriving crypto-sphere through groundbreaking analytics solutions.

I-Virtual

Venture Round in 2023
i-Virtual is a deep-tech company focused on advanced sensing technologies that enhance artificial intelligence's ability to accurately perceive human biological signals. Its primary product, Saphere, is a video-based engine for measuring and processing vital signs, allowing for a seamless integration into various industries such as insurance, wellness, connected devices, and software-as-a-service providers. By enabling real-time, non-contact measurement of vital signs through a simple 30-second selfie, i-Virtual transforms AI into an intuitive partner for its users. This innovation not only makes vital sign monitoring more accessible but also empowers clients to achieve greater levels of personalization, efficiency, and engagement in everyday health and well-being.

Dottxt

Seed Round in 2023
Dottxt is a software development company that specializes in machine learning models designed for information extraction and classification. By offering an application programming interface (API), Dottxt enables businesses to integrate advanced language processing capabilities into their operations. The company also provides customized technology advisory and consulting services, helping clients optimize their processes and achieve strategic objectives. Through its innovative solutions, Dottxt aims to enhance the efficiency and effectiveness of information management in various sectors.

Tabnine

Series B in 2023
Tabnine, Inc. is an artificial intelligence company based in Toronto, Canada, that specializes in autocompletion software for developers. Founded in 2018, Tabnine offers an AI-powered coding assistant designed to help development teams enhance their coding efficiency while maintaining privacy and security. The platform predicts and autocompletes lines of code based on context and learned programming patterns, enabling developers to write software more seamlessly. Additionally, it includes features for analyzing code snippets and leveraging open-source code effectively. Tabnine's capabilities extend to providing an AI chat agent that can explain code and generate code, tests, and documentation from plain language prompts, thereby reducing errors and streamlining the software development process. Tabnine operates as a subsidiary of Codota Dot Com Ltd.

Fentech

Seed Round in 2023
Fentech offers platform for Decision Intelligence that guarantees reliable forecasting. Anticipate your actions on prices, provisionning and product assortments.

Tilak Healthcare

Venture Round in 2023
Tilak Healthcare SAS is a Paris-based company that specializes in developing mobile games intended for use as diagnostic and rehabilitation tools for chronic diseases. Founded in 2016, the company creates clinically validated mobile games that allow health professionals to monitor patients with chronic conditions, such as macula diseases, through engaging gameplay. By combining entertainment with medical monitoring, Tilak Healthcare aims to enhance patient participation in their health management and improve overall health outcomes and quality of life.

HarfangLab

Series A in 2023
HarfangLab specializes in developing advanced software for threat detection and response, aimed at enhancing the security of corporate endpoints against cyberattacks. Their platform integrates with existing third-party cybersecurity solutions to provide improved visibility and control over systems. The company's expertise is bolstered by a team experienced in both defensive and offensive cyber operations, having previously collaborated with the French National Agency for the Security of Information Systems, the French Ministry of Defense, and leading cybersecurity firms. By streamlining the processes of detection, investigation, and neutralization of threats, HarfangLab enables organizations to efficiently manage and mitigate cybersecurity risks.

Nano Corp

Seed Round in 2023
Nano Corp offers IT infrastructure managers the control of increasingly complex networks. The company's features include targeted and contextualized alerts, real-time analysis of all network flows, automatic mapping of networks by flows, visibility on all tunnels and virtual networks, network health status, detection of plateaus and bottlenecks, advanced network cybersecurity features, integration with fleet management tools as well as cyber siem or soar tools.

Aviwell

Seed Round in 2023
Aviwell is focused on creating healthy, natural, and sustainable solutions aimed at enhancing animal health and growth, thereby contributing to global nourishment. The company operates a microbiota-based discovery platform that leverages artificial intelligence and machine learning to bridge digital and life sciences. By developing innovative food products, Aviwell seeks to provide valuable insights into animal health, growth, and performance, ultimately supporting the agri-food industry in its efforts to sustainably meet the needs of a growing population.

Sonio

Series A in 2023
Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

Gleamer

Series B in 2023
Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Djust

Series A in 2023
DJUST is a provider of a cloud-based B2B platform that facilitates the rapid launch of e-commerce and e-procurement solutions for businesses. The company combines digital showrooms, an e-commerce marketplace, and customer relationship management (CRM) tools into a single integrated product. This streamlined approach allows clients to easily set up and expand their online operations, enhancing their ability to engage in digital commerce effectively. By offering a comprehensive solution, DJUST aims to simplify the process for businesses looking to establish or upgrade their online presence.

Greenbids

Seed Round in 2023
Greenbids specializes in developing artificial intelligence and machine learning models aimed at decarbonizing digital advertising. The company focuses on creating advanced algorithms that track and measure carbon emissions associated with digital ad campaigns, providing businesses with valuable data visualization and insights. Through its innovative dashboard, Greenbids enables companies to quantify their media carbon footprint, thereby improving their media performance while minimizing environmental impact. The company's mission is to transform digital advertising into a more resource-efficient process, contributing to a sustainable future for the industry.

Hema.to

Seed Round in 2023
Hema.to is a developer of clinical support software that specializes in automated, AI-powered detection suggestions for blood cancer, utilizing flow cytometry data. The company's platform offers comprehensive decision support, taking users from raw flow files to complete diagnostic reports. By focusing on the needs of hematology laboratories, Hema.to aims to enhance operational efficiency while ensuring high-quality results. Its tools are specifically designed to meet the unique requirements of clinical flow, empowering labs to provide better patient care through advanced technology.

SESAMm

Series B in 2023
SESAMm is a fintech company focused on leveraging big data and artificial intelligence to enhance investment strategies. The firm specializes in analyzing vast amounts of web content through natural language processing and machine learning to generate analytics and investment signals. Its platforms, TextReveal and SignalReveal, provide comprehensive solutions for alpha research, catering to both fundamental and quantitative investment needs. With a team of 90 professionals located in cities such as Paris, New York, and Tokyo, SESAMm collaborates with prominent hedge funds, banks, and asset management firms globally. Additionally, the company emphasizes responsible and sustainable investing, offering insights that assist private equity firms, asset managers, and corporations in effectively managing their assets.

Pili

Series A in 2023
PILI Inc. is a company based in Paris, France, that specializes in researching and manufacturing bio-fabricated colors derived from microorganisms. Founded in 2012, the company focuses on designing enzymes and fermentation biotechnologies that convert sugar into sustainable and long-lasting dyes and pigments. PILI produces renewable inks as an eco-friendly alternative to traditional toxic and non-recyclable options. The company emerged from a collaboration among a biologist, a designer, and a financial analyst in a biohacker space, leading to the creation of innovative products like a pen fed by bacteria. By utilizing microorganisms, PILI aims to replace petrochemical and non-sustainable vegetable dyes, promoting sustainable development while also helping businesses reduce costs.

Qbeast Analytics

Seed Round in 2023
Qbeast enables faster and cost-efficient data lakes for BI and Machine Learning through smarter data layout, powered by the most advanced open-source data lake format. We are a spin-off of the Barcelona Supercomputing Center.

Zymvol Biomodeling

Seed Round in 2023
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.

Giskard

Seed Round in 2022
Giskard is a developer of a visual quality management platform specifically designed for testing artificial intelligence models. The platform automates the testing process, allowing users to visually inspect AI models for bugs and receive actionable feedback. By providing alerts on poor model performance in production, Giskard enables data scientists, engineers, and business professionals to effectively manage AI risks while ensuring the quality, security, and compliance of their AI systems. This comprehensive approach facilitates the development of improved AI models, helping enterprises navigate the complexities associated with AI implementation.

Arsen

Seed Round in 2022
Arsen is a developer of a phishing simulation platform aimed at enhancing cybersecurity awareness within organizations. The platform replicates real-world social engineering threats, including phishing, business email compromise, smishing, and vishing attacks, to educate employees on recognizing and responding to these risks. It offers lightweight training content that is quick and easy to integrate into busy schedules, reinforcing a strong cybersecurity culture. Additionally, Arsen monitors emerging threat signals, such as suspicious domains and data leaks, allowing organizations to anticipate and mitigate potential attacks before they occur. By partnering with leading global cybersecurity experts, Arsen provides a comprehensive solution that empowers businesses to safeguard themselves against modern threats.

Hummink

Seed Round in 2022
Hummink is a Paris-based company founded in 2020 that specializes in additive manufacturing technology focused on nanoscale design and production. The company utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator to achieve capillary deposition of various liquids. This innovative approach allows clients in the semiconductor and molecular diagnostic industries to create large objects while maintaining high resolution and precision on substrates ranging from millimetric to centimetric scales. Hummink's advancements in nano-printing technology position it as a valuable player in the field of precision manufacturing.

Qantev

Series A in 2022
Qantev operates an AI-driven health claims platform designed for health and life insurance companies. The platform utilizes a proprietary algorithm to enhance the configuration of provider networks and identify optimal participants, thereby assisting insurers in minimizing claims leakage. By leveraging historical claims data, Qantev's technology empowers health insurance teams to gain valuable insights, facilitating data-driven decision-making and the development of effective business strategies. This innovative approach aims to improve efficiency and accuracy in claims operations across the global insurance market.

Namla

Pre Seed Round in 2022
Namla offers a Cloud Edge Orchestration platform designed to enable companies to automatically deploy and manage extensive cloud edge infrastructures. By integrating Distributed Edge Orchestration with SD-WAN and multi-cloud support, the platform enhances the performance and availability of edge deployments. This technology allows businesses to process data closer to connected machines and devices, fostering the implementation of the Internet of Things. Namla's solution empowers both businesses and managed service providers to deliver efficient hybrid-cloud native edge systems, streamlining operations and improving overall service delivery.

TakeTurns

Seed Round in 2022
TakeTurns is a collaboration platform that enables businesses to securely share, collect, and collaborate on essential documents and files with external parties, including clients, vendors, partners, and investors. By transforming the chaos of emails, attachments, and shared folders into an organized and secure environment, TakeTurns offers a structured workflow known as TakeTurns Flow™. The platform seamlessly integrates with users' daily workflows and other applications, facilitating the sharing, requesting, and reviewing of documents. This functionality enhances collaboration and communication between businesses and their external stakeholders, streamlining processes and improving overall efficiency.

Corporatings

Seed Round in 2022
Corporatings is a financial intelligence platform that seeks to transform how individuals access company-published financial information. By harnessing the capabilities of artificial intelligence, the company specializes in extracting and processing both structured and unstructured fundamental data from various corporate publications. This approach allows financial professionals to easily access and analyze essential business data, promoting greater transparency and reliability. Through its proprietary database and user-friendly interfaces, Corporatings aims to simplify the daily tasks of users, enhancing their overall experience in navigating financial information.

Moments Lab

Series A in 2022
Moments Lab is a media valorization platform focused on enhancing the efficiency of content creation for various media professionals, including TV networks, sports rights holders, production companies, and journalists. The platform utilizes MXT Multimodal AI to address video indexing challenges, allowing users to make audiovisual content searchable and enabling quicker access to key moments for storytelling. Moments Lab offers several solutions, including Just Index for metadata extraction, Media Hub for advanced media asset management, Live Asset Manager for real-time access to live streams, and Media Marketplace for monetizing media libraries. By improving productivity and reducing the time needed to build video stories, Moments Lab empowers its clients to better manage live recordings, clip highlights, and license content. The platform aims to provide immediate returns on investment by increasing the reusability and discoverability of content across various search engine platforms. Clients include notable organizations such as Hearst Corporation, Agence France Presse, and the French Football Federation, illustrating the platform's global reach and impact on the media industry.

Cyrebro

Series C in 2022
Cyrebro is a cybersecurity company that specializes in Managed Detection and Response solutions, offering a cloud-based Security Operations Center (SOC) platform. This platform is designed to rapidly detect, analyze, investigate, and respond to cyber threats, providing organizations with the capabilities typically found in state-level SOCs. Cyrebro's solution includes a proprietary Next Gen SIEM and Detection Engine for log ingestion, detection, and orchestration, along with a Security Orchestration, Automation, and Response (SOAR) system for correlations and investigations. The service covers various aspects of cybersecurity, including strategic monitoring, threat hunting, and incident response, supported by over 1,500 proprietary detection algorithms that enhance threat detection efficiency. Additionally, Cyrebro's technology-agnostic approach allows it to integrate with hundreds of tools and systems, making it suitable for a wide range of businesses facing diverse cyber risks.

Vibe

Seed Round in 2022
Vibe is a developer of a programmatic advertising platform that specializes in detecting and targeting audiences through keyword identification. The platform enhances customer engagement by pinpointing specific sections that can improve attention and interaction. By creating targeted strategies and campaigns based on keyword searches, Vibe enables web agencies and advertisers to effectively retarget users and capture their intent. This capability ultimately aims to boost sales and improve the overall effectiveness of advertising efforts in the digital landscape.

Sonio

Seed Round in 2022
Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

LynxCare

Series A in 2022
LynxCare, Inc. is an AI-powered data platform founded in 2015 and based in San Francisco, California. The company specializes in collecting and analyzing both structured and unstructured data from various sources to deliver actionable insights for medical professionals in hospitals and clinics. LynxCare's platform aggregates clinical data and patient-reported outcomes, providing custom tools that enhance clinical efficiency and improve the quality of care. By enabling healthcare practitioners to mine their legacy data and access real-time information, LynxCare aims to improve healthcare outcomes and tailor patient care effectively.

Cosmian

Venture Round in 2022
Cosmian operates as a decentralized Confidential Data Intelligence Platform that focuses on privacy by design, utilizing advanced cryptographic techniques such as functional and homomorphic encryption. This innovative approach allows organizations to analyze and derive insights from encrypted data without exposing the underlying information. By offering solutions tailored for businesses that handle sensitive or confidential data, Cosmian significantly mitigates the risks associated with data processing. Their platform enables clients to maintain their existing data analysis workflows while enhancing data protection and privacy. This capability is particularly beneficial for sectors such as finance and security, where the secure handling and transmission of private information are paramount.

Therapixel

Series B in 2022
Therapixel SA is a French company specializing in the development of artificial intelligence-based medical image analytics software aimed at enhancing surgical procedures. Founded in 2013 and headquartered in Valbonne, France, Therapixel offers a range of products designed to assist healthcare professionals, including Radvise, an automatic image reading solution; Fluid, a touchless navigation system for surgical environments; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing outpatient imaging exams. The company's technology focuses on providing timely and relevant information to surgeons, ensuring they can access critical medical images before or during surgical operations. With additional locations in various countries, including Australia, China, and several nations across Europe and Latin America, Therapixel is committed to improving breast cancer detection and characterization through its innovative software solutions.

SUN ZU Lab

Seed Round in 2022
SUN ZU Lab is an independent provider of liquidity analytics for crypto professionals. Clients can use SUN ZU Lab's liquidity analytics to determine whether their order book is strong on its own and in comparison to key competitors. With a clear and demonstrable value proposition, clients are better equipped to serve existing investors and attract new ones. SUN ZU Lab's mission is to increase transparency in the thriving crypto-sphere through groundbreaking analytics solutions.

Nuclia

Seed Round in 2022
Nuclia is a company that offers an end-to-end API designed for the development of AI-powered search engines. It specializes in indexing unstructured data from various internal and external sources, which enhances search results. The API can parse documents, extract visual content, and transcribe audio and video, allowing users to efficiently search for diverse types of data across multiple formats and languages. By simplifying the complex process of building AI-driven search capabilities, Nuclia enables developers to create effective search engines tailored to their specific data needs.

Blindnet

Pre Seed Round in 2022
Blindnet operates between New York and Paris, providing developer tools and cloud infrastructure services aimed at enhancing product safety and user trust. The company's platform facilitates the implementation of privacy and security protocols for data-in-motion, allowing businesses to minimize the collection of sensitive user information. This approach reduces the risk of data exposure in the event of a breach and ensures compliance with privacy regulations. By offering automated privacy intelligence and dynamic data governance, Blindnet enables companies to create privacy-preserving experiences for their customers.

Alice & Bob

Series A in 2022
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company's innovative technology features self-correcting superconducting quantum bits, which allow for fault-tolerant quantum computing. This capability enables the execution of any quantum algorithm, thereby assisting industries and researchers in addressing complex challenges across various fields. By focusing on developing advanced quantum computing solutions, Alice & Bob aims to facilitate breakthroughs in solving significant problems in quantum research and industry applications.

Seyna

Series A in 2022
Seyna is a digital insurance company based in Paris, France, established in 2018. It specializes in providing white label damage insurance products tailored for various needs. Its offerings include rental insurance, coverage for tuition fees at private institutions in case of illness, protection for self-employed workers' equipment, and cancellation cover for ticketing. Seyna also operates an insurance creation, management, and distribution platform designed for brokers, facilitating the customization and easy management of insurance products across different sectors, including non-life insurance.

Indeez

Series A in 2022
Indeez is an insurtech company founded in 2020 and based in Paris, France, that specializes in income protection solutions for independent workers, gig workers, and freelancers. The company offers coverage for various everyday life events such as sickness, maternity, paternity, and work-related accidents, ensuring that these workers have access to essential protections. Indeez's proprietary technology facilitates a user-friendly interface, allowing platform workers to obtain affordable and usage-based insurance. Additionally, the technology provides platforms with a streamlined overview of their multi-country programs, enabling them to manage community safety more effectively. By focusing on the unique needs of independent workers, Indeez aims to enhance the sustainability of gig work and build loyalty among its users.

SeqOne Genomics

Series A in 2022
Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGS has had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.

Codenotary

Series B in 2022
CodeNotary, founded in 2018 by Moshe Bar and Dennis Zimmer in Houston, Texas, operates a software supply chain platform focused on providing tamperproof ledger services. The company offers an immutable and tamper-evident database support system, restoring trust and integrity to digital applications by enabling secure data storage that protects against unauthorized changes or tampering.

Continuity

Seed Round in 2021
Continuity offers a software-as-a-service (SaaS) platform that utilizes artificial intelligence and open data to identify outdated or invalid insurance contracts. The platform operates across four key product lines: Professional Indemnity, Commercial Property, Construction Workers Insurance, and Directors & Officers Liability. By analyzing data consistently and at scale, Continuity provides insurers with a comprehensive view of small and medium-sized enterprises (SMEs), ensuring that each business is adequately covered throughout its lifecycle. This innovative approach helps to enhance the accuracy and reliability of insurance coverage for SMEs.

EyePick

Seed Round in 2021
EyePick specializes in automating manual tasks across various industries, including food, logistics, retail, manufacturing, and pharmaceuticals, through the use of vision-guided robots and advanced machine-learning technologies. The company develops robotic systems that can see, understand, and interact with their environment, allowing for efficient automation of tasks such as pick and drop, pick and place, bin picking, and sorting. By providing these innovative automation solutions, EyePick helps businesses streamline their operations and enhance productivity, reducing reliance on manual labor in critical processes.

Tilak Healthcare

Venture Round in 2021
Tilak Healthcare SAS is a Paris-based company that specializes in developing mobile games intended for use as diagnostic and rehabilitation tools for chronic diseases. Founded in 2016, the company creates clinically validated mobile games that allow health professionals to monitor patients with chronic conditions, such as macula diseases, through engaging gameplay. By combining entertainment with medical monitoring, Tilak Healthcare aims to enhance patient participation in their health management and improve overall health outcomes and quality of life.

Quantum Dice

Pre Seed Round in 2021
Quantum Dice is an award-winning spin-out from the University of Oxford specializing in quantum technology. The company develops quantum random number generators (QRNGs) that produce unbiased, true random numbers essential for modern communication technologies. These devices generate cryptographically secure random numbers that enhance security across various commercial applications. Quantum Dice's self-certified QRNGs are designed to function solely from quantum processes, ensuring improved encryption systems while safeguarding against external influences. This technology aims to provide enhanced security for an increasingly connected future.

Mirakl

Series E in 2021
Mirakl is a provider of an advanced enterprise marketplace software-as-a-service platform designed to assist brands and retailers in launching and scaling their marketplaces. The platform enables organizations in both B2B and B2C sectors to effectively manage their marketplace operations, ensuring they meet growing customer expectations. Mirakl's solution emphasizes the identification and onboarding of new sellers, while its flexible application programming interfaces (APIs) seamlessly integrate with existing e-commerce systems. This allows businesses to enhance the quality of their product offerings and improve overall productivity, agility, and growth.

Flash Therapeutics

Debt Financing in 2021
Flash Therapeutics is a biotechnology company based in Labège, France, specializing in gene and cell-based therapies through its proprietary lentiviral platform. Established in 2005 and formerly known as Vectalys SAS, the company focuses on developing advanced viral vector technologies to transduce difficult-to-transfect cells, including primary cells and stem cells. Flash Therapeutics offers a range of services, including gene silencing, gene over-expression, cell-based assay development, and protein expression. It also conducts preclinical trials for gene therapy and produces concentrated viral vectors for research purposes. The company is committed to creating innovative solutions for drug screening and the development of cellular and animal models to validate candidate genes.

Djust

Venture Round in 2021
DJUST is a provider of a cloud-based B2B platform that facilitates the rapid launch of e-commerce and e-procurement solutions for businesses. The company combines digital showrooms, an e-commerce marketplace, and customer relationship management (CRM) tools into a single integrated product. This streamlined approach allows clients to easily set up and expand their online operations, enhancing their ability to engage in digital commerce effectively. By offering a comprehensive solution, DJUST aims to simplify the process for businesses looking to establish or upgrade their online presence.

Azalea Vision

Seed Round in 2021
Developer of optical care technology designed to focus on smart contact lens solutions for clinical needs. The company develops a fully encapsulated platform with an artificial iris embedded in an off-the-shelf contact lens, thereby helping patients who suffer from iris deficiencies, aberrations, and light sensitivity or photophobia to benefit from the smart contact lenses.

MyC

Venture Round in 2021
MyC is a software platform that specializes in health data collection and management. It offers an application designed to gather health information from various sources and provides predictive analysis to support employee health initiatives. By utilizing real-time data, MyC automates reporting and enhances operational control, allowing employers to optimize employee health outcomes while reducing risk exposure for the company.

Nano Corp

Seed Round in 2021
Nano Corp offers IT infrastructure managers the control of increasingly complex networks. The company's features include targeted and contextualized alerts, real-time analysis of all network flows, automatic mapping of networks by flows, visibility on all tunnels and virtual networks, network health status, detection of plateaus and bottlenecks, advanced network cybersecurity features, integration with fleet management tools as well as cyber siem or soar tools.

HarfangLab

Seed Round in 2021
HarfangLab specializes in developing advanced software for threat detection and response, aimed at enhancing the security of corporate endpoints against cyberattacks. Their platform integrates with existing third-party cybersecurity solutions to provide improved visibility and control over systems. The company's expertise is bolstered by a team experienced in both defensive and offensive cyber operations, having previously collaborated with the French National Agency for the Security of Information Systems, the French Ministry of Defense, and leading cybersecurity firms. By streamlining the processes of detection, investigation, and neutralization of threats, HarfangLab enables organizations to efficiently manage and mitigate cybersecurity risks.

AQEMIA

Series A in 2021
AQEMIA is a pharmatech company focused on drug discovery, utilizing a platform that integrates machine learning with quantum-inspired physics. This innovative approach allows for the efficient identification of new drug candidates aimed at specific therapeutic targets. By employing advanced algorithms, AQEMIA's platform is capable of predicting the interactions and affinities between potential drug molecules and their targets. This methodology not only accelerates the drug discovery process but also contributes to a growing pipeline of viable drug candidates for various medical applications.

iBanFirst

Private Equity Round in 2021
iBanFirst, established in 2012 and headquartered in Brussels, Belgium, specializes in international money transfers and foreign exchange payments. With offices in Paris, Dijon, and Antwerp, the company caters to small and medium-sized enterprises (SMEs) worldwide, offering a user-friendly online platform for multicurrency transactions. iBanFirst provides real-time, competitive exchange rates, currency market alerts, and streamlined accounting, enabling clients to pay beneficiaries in their local currencies securely and efficiently.

Blindnet

Pre Seed Round in 2021
Blindnet operates between New York and Paris, providing developer tools and cloud infrastructure services aimed at enhancing product safety and user trust. The company's platform facilitates the implementation of privacy and security protocols for data-in-motion, allowing businesses to minimize the collection of sensitive user information. This approach reduces the risk of data exposure in the event of a breach and ensures compliance with privacy regulations. By offering automated privacy intelligence and dynamic data governance, Blindnet enables companies to create privacy-preserving experiences for their customers.

Cryptosense

Venture Round in 2021
Cryptosense SA specializes in automated analysis solutions for cryptographic systems, providing tools to assess vulnerabilities and enhance security. Its flagship product, Cryptosense Analyzer, adapts its attack strategies to evaluate the behavior of cryptographic interfaces, while Cryptosense App Tracer identifies common mistakes in cryptography and key management. Additionally, Cryptosense Monitor offers comparison and alert capabilities, and Cryptosense Simulator replicates hardware security module (HSM) behavior. The company's software is informed by advanced research from leading cryptography labs and is continually updated through internal R&D and collaborations with academic institutions. This technology is utilized by a diverse range of clients, including technology firms, payment system operators, banks, and secure hardware manufacturers, helping them to mitigate risks associated with data breaches and enhance their security posture. Cryptosense was founded in 2013 and is headquartered in Paris, France.

Nuclia

Pre Seed Round in 2021
Nuclia is a company that offers an end-to-end API designed for the development of AI-powered search engines. It specializes in indexing unstructured data from various internal and external sources, which enhances search results. The API can parse documents, extract visual content, and transcribe audio and video, allowing users to efficiently search for diverse types of data across multiple formats and languages. By simplifying the complex process of building AI-driven search capabilities, Nuclia enables developers to create effective search engines tailored to their specific data needs.

AQEMIA

Seed Round in 2021
AQEMIA is a pharmatech company focused on drug discovery, utilizing a platform that integrates machine learning with quantum-inspired physics. This innovative approach allows for the efficient identification of new drug candidates aimed at specific therapeutic targets. By employing advanced algorithms, AQEMIA's platform is capable of predicting the interactions and affinities between potential drug molecules and their targets. This methodology not only accelerates the drug discovery process but also contributes to a growing pipeline of viable drug candidates for various medical applications.

Pixyl

Venture Round in 2021
Pixyl is a developer of a neuroimaging cloud platform that enhances patient care for radiologists by providing critical decision-making information from neuroimaging data. Their platform, Pixyl.Neuro, utilizes advanced machine learning techniques to automatically analyze MRI images, offering detailed insights into brain structures such as grey matter, white matter, and intracranial volumes. This capability allows clinicians to extract neuroimaging biomarkers that improve decision-making in both clinical studies and routine practice, particularly in the context of multiple sclerosis, stroke, and neurodegenerative diseases. By integrating seamlessly into the workflows of imaging contract research organizations, neuroradiologists, and neurologists, Pixyl aims to facilitate data-driven and value-based patient care, ensuring that vital information is accessible to healthcare providers when it is most needed.

Mablink Bioscience

Seed Round in 2021
Mablink Bioscience is a biotechnology company focused on developing a new class of cancer therapies known as Antibody Drug Conjugates (ADCs). The company specializes in designing homogeneous, plasma-stable ADCs that maintain their original pharmacological properties while achieving a high drug-to-antibody ratio (DAR). This innovative approach aims to provide healthcare professionals with enhanced treatment options for cancer patients, ultimately improving therapeutic outcomes.

Ornikar

Series C in 2021
Ornikar SAS is an online driving school based in Paris, France, established in 2014. The company specializes in providing an affordable and streamlined approach to obtaining a driving license, catering to the needs of current and future generations. Ornikar offers a platform where candidates can learn and practice traffic laws, supported by a network of state-qualified instructors who deliver mobile driving lessons at reduced prices. In addition to facilitating access to driving licenses, Ornikar also provides tailored options for first-time car buyers and young driver insurance, enhancing the overall learning experience and promoting automotive mobility.

Moments Lab

Series A in 2021
Moments Lab is a media valorization platform focused on enhancing the efficiency of content creation for various media professionals, including TV networks, sports rights holders, production companies, and journalists. The platform utilizes MXT Multimodal AI to address video indexing challenges, allowing users to make audiovisual content searchable and enabling quicker access to key moments for storytelling. Moments Lab offers several solutions, including Just Index for metadata extraction, Media Hub for advanced media asset management, Live Asset Manager for real-time access to live streams, and Media Marketplace for monetizing media libraries. By improving productivity and reducing the time needed to build video stories, Moments Lab empowers its clients to better manage live recordings, clip highlights, and license content. The platform aims to provide immediate returns on investment by increasing the reusability and discoverability of content across various search engine platforms. Clients include notable organizations such as Hearst Corporation, Agence France Presse, and the French Football Federation, illustrating the platform's global reach and impact on the media industry.

I-Virtual

Seed Round in 2021
i-Virtual is a deep-tech company focused on advanced sensing technologies that enhance artificial intelligence's ability to accurately perceive human biological signals. Its primary product, Saphere, is a video-based engine for measuring and processing vital signs, allowing for a seamless integration into various industries such as insurance, wellness, connected devices, and software-as-a-service providers. By enabling real-time, non-contact measurement of vital signs through a simple 30-second selfie, i-Virtual transforms AI into an intuitive partner for its users. This innovation not only makes vital sign monitoring more accessible but also empowers clients to achieve greater levels of personalization, efficiency, and engagement in everyday health and well-being.

Holded

Series B in 2021
Holded is a developer of cloud-based business management software aimed at small and medium-sized enterprises. Its platform offers a comprehensive suite of tools that encompasses financial management, including accounting and invoicing, as well as human resources, customer relationship management, project management, and inventory management. By providing these integrated solutions, Holded enables organizations to streamline operations, enhance productivity, and manage various aspects of their business more effectively. The software aims to help businesses increase sales while reducing costs, ultimately contributing to improved overall efficiency and management.

Qantev

Seed Round in 2020
Qantev operates an AI-driven health claims platform designed for health and life insurance companies. The platform utilizes a proprietary algorithm to enhance the configuration of provider networks and identify optimal participants, thereby assisting insurers in minimizing claims leakage. By leveraging historical claims data, Qantev's technology empowers health insurance teams to gain valuable insights, facilitating data-driven decision-making and the development of effective business strategies. This innovative approach aims to improve efficiency and accuracy in claims operations across the global insurance market.

Moment

Seed Round in 2020
Get paid on time. The b2b invoice protection against late payments, crafted for SMBs.

Spectral Augmented Industries

Series A in 2020
Spectral Augmented Industries offers an internal SaaS platform for augmented maintenance that helps and trains technicians during maintenance operations.

Hummink

Seed Round in 2020
Hummink is a Paris-based company founded in 2020 that specializes in additive manufacturing technology focused on nanoscale design and production. The company utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator to achieve capillary deposition of various liquids. This innovative approach allows clients in the semiconductor and molecular diagnostic industries to create large objects while maintaining high resolution and precision on substrates ranging from millimetric to centimetric scales. Hummink's advancements in nano-printing technology position it as a valuable player in the field of precision manufacturing.

Gleamer

Series A in 2020
Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Mirakl

Series D in 2020
Mirakl is a provider of an advanced enterprise marketplace software-as-a-service platform designed to assist brands and retailers in launching and scaling their marketplaces. The platform enables organizations in both B2B and B2C sectors to effectively manage their marketplace operations, ensuring they meet growing customer expectations. Mirakl's solution emphasizes the identification and onboarding of new sellers, while its flexible application programming interfaces (APIs) seamlessly integrate with existing e-commerce systems. This allows businesses to enhance the quality of their product offerings and improve overall productivity, agility, and growth.

PricingHUB

Seed Round in 2020
PricingHUB is a software-as-a-service company that offers a dynamic pricing solution designed for retailers and e-commerce businesses. The platform utilizes machine learning and artificial intelligence to optimize pricing strategies by analyzing price elasticity and competitive contexts. PricingHUB aims to simplify pricing optimization for its clients by consolidating relevant data sources, allowing them to make informed pricing decisions that align with their business objectives. The company invests in research and development, collaborating with European pricing experts and mathematicians to develop robust algorithms and transparent performance measurement methods. By leveraging data and digitalization, PricingHUB seeks to extend dynamic pricing capabilities beyond online platforms to physical retail stores, ultimately enhancing pricing strategies and improving profit margins.

Honing Biosciences

Pre Seed Round in 2020
Honing Biosciences SAS is a bio-therapeutics company based in Paris, France, specializing in the development and enhancement of cell-based therapies for cancer and other chronic diseases. The company utilizes its proprietary molecular CellTune technology to create tunable cell therapeutics that enable precise control over the dynamic delivery of proteins in patients. This innovation allows for the regulation of protein expression at the cell surface and the secretion of therapeutic agents such as enzymes, cytokines, and antibodies, which can be adapted based on the clinical progression of a patient's condition. Honing Biosciences also offers therapies like CAR-T cell therapy and checkpoint inhibitors, which aim to improve treatment efficacy while minimizing adverse effects associated with earlier therapeutic generations. Established in 2018, the company focuses on advancing immunotherapy and reconstituting cell therapies to better engage the body’s immune system in combating diseases.

inHEART

Seed Round in 2020
inHEART specializes in advanced precision medicine for cardiology, utilizing artificial intelligence to enhance the care of patients with cardiac diseases. The company develops innovative software solutions that create a digital twin of the heart, transforming preoperative medical images into a detailed model. This technology aids cardiologists in diagnosing, planning, and navigating procedures related to heart rhythm disorders, such as arrhythmias and heart failure. By bridging the gap between radiology and cardiology, inHEART aims to improve treatment personalization and reduce procedure durations and failure rates, ultimately advancing patient care in the field of cardiovascular medicine.

Codenotary

Series A in 2020
CodeNotary, founded in 2018 by Moshe Bar and Dennis Zimmer in Houston, Texas, operates a software supply chain platform focused on providing tamperproof ledger services. The company offers an immutable and tamper-evident database support system, restoring trust and integrity to digital applications by enabling secure data storage that protects against unauthorized changes or tampering.

Quortex

Seed Round in 2020
Quortex, established in 2018 and located in Cesson-Sévigné, France, specializes in developing artificial intelligence-driven software solutions aimed at optimizing content delivery over the internet. The company focuses on enhancing video streaming services by leveraging advanced cloud technologies to adapt to varying network conditions, infrastructure capabilities, and audience demands. Its platform automatically adjusts cloud resources in real-time, ensuring an optimal user experience while significantly reducing infrastructure and network costs for clients. Through this innovative approach, Quortex aims to transform over-the-top (OTT) services, making them more efficient and cost-effective in an increasingly dynamic digital landscape.

iBanFirst

Series C in 2020
iBanFirst, established in 2012 and headquartered in Brussels, Belgium, specializes in international money transfers and foreign exchange payments. With offices in Paris, Dijon, and Antwerp, the company caters to small and medium-sized enterprises (SMEs) worldwide, offering a user-friendly online platform for multicurrency transactions. iBanFirst provides real-time, competitive exchange rates, currency market alerts, and streamlined accounting, enabling clients to pay beneficiaries in their local currencies securely and efficiently.

The Hotels Network

Series B in 2020
The Hotels Network is a growth platform designed to enhance the online booking experience for hotels. It provides technology that enables hotels to attract, engage, and convert visitors through predictive personalization, ensuring each guest has a unique user experience. The platform offers tools that facilitate comparison of reviews and prices, alongside a comprehensive suite of personalization options and predictive analytics. Its aim is to increase direct bookings for hotels while also improving transparency for both customers and hotel operators. With a team of specialists in hospitality, product design, and consumer marketing, The Hotels Network operates from locations in Barcelona, San Francisco, Mexico City, and Singapore, positioning itself as a leader in hotel management software.

Shipup

Series A in 2020
Shipup is a technology company that specializes in enhancing the post-purchase experience for online retailers by providing a comprehensive package tracking platform. This platform allows e-merchants to monitor parcel deliveries and report any delivery issues. Shipup facilitates proactive and branded shipping notifications at every stage of the delivery process, ensuring that customers are kept informed. Additionally, the service automates refunds for late or undelivered packages, thereby improving customer satisfaction and loyalty. By transforming delivery into a key aspect of marketing and customer success, Shipup helps e-commerce businesses create a more engaging and efficient experience for their customers.

Alice & Bob

Seed Round in 2020
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company's innovative technology features self-correcting superconducting quantum bits, which allow for fault-tolerant quantum computing. This capability enables the execution of any quantum algorithm, thereby assisting industries and researchers in addressing complex challenges across various fields. By focusing on developing advanced quantum computing solutions, Alice & Bob aims to facilitate breakthroughs in solving significant problems in quantum research and industry applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.